American Vanguard Corporation (AVD) Insider Trading

Last 12 months

Insiders bought $237k on the open market and sold nothing.

Net open-market

+$237k

4 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

3 / 0

executives and directors

Last open-market buy

Aug 2026

Aug 17, 2026

Get an email when AVD's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 18	Cruiser Capital Advisors, LLC Large holder	SoldNo plan	556,580	$2.20	$1.22M	87%	Form 4
Aug 17	Steven D Macicek Director	Bought	19,000	$2.09	$40k	24%	Form 4
Jun 3	Douglas Kaye CHIEF EXECUTIVE OFFICER	Bought	5,000	$2.50	$13k	1.7%	Form 4
May 19	Patrick E Gottschalk Director	Bought	25,000	$2.70	$68k	15%	Form 4
May 12 – 13	Patrick E Gottschalk Director	Bought 2 parts	40,000	$2.94 average	$117k	32%	Form 4
Sep 4, 2025	Peter Eilers See Remarks	SoldNo plan	6,000	$5.35	$32k	16%	Form 4
Jun 11, 2025	Douglas Kaye CHIEF EXECUTIVE OFFICER	Bought	2,000	$4.67	$9k	0.7%	Form 4
Dec 13, 2024	Peter Eilers See Remarks	SoldNo plan	3,000	$5.35	$16k	7.3%	Form 4
Nov 15, 2024	Steven D Macicek Director	Bought	12,000	$5.97	$72k	62%	Form 4

Aug 18No plan
Cruiser Capital Advisors, LLC
Large holder · sold 556,580 at $2.20
$1.22M
87% of stake
Aug 17
Steven D Macicek
Director · bought 19,000 at $2.09
$40k
24% of stake
Jun 3
Douglas Kaye
CHIEF EXECUTIVE OFFICER · bought 5,000 at $2.50
$13k
1.7% of stake
May 19
Patrick E Gottschalk
Director · bought 25,000 at $2.70
$68k
15% of stake
May 12 – 13
Patrick E Gottschalk
Director · bought 40,000 at avg $2.94
$117k
32% of stake
Sep 4, 2025No plan
Peter Eilers
See Remarks · sold 6,000 at $5.35
$32k
16% of stake
Jun 11, 2025
Douglas Kaye
CHIEF EXECUTIVE OFFICER · bought 2,000 at $4.67
$9k
0.7% of stake
Dec 13, 2024No plan
Peter Eilers
See Remarks · sold 3,000 at $5.35
$16k
7.3% of stake
Nov 15, 2024
Steven D Macicek
Director · bought 12,000 at $5.97
$72k
62% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch AVD, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Agricultural Chemicals

UANCvr Partners, LP

ENFYEnlightify Inc.

SMGScotts Miracle-Gro Co.

VREOFVireo Growth Inc.

ADMAAdma Biologics Inc.

NATRNature's Sunshine Products Inc.

AAWHAscend Wellness Holdings, Inc.

HCMHUTCHMED (China) Ltd

Spot a number that looks wrong? Check it in AVD's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing AVD

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.